Bridged bicyclic imides as anxiolytics and antidepressants

Details Bridged bicyclic imides as anxiolytics and antidepressants Bridged bicyclic imides as anxiolytics and antidepressants

1989-05-23

1993-09-07

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514216, 514256, 544230, 544295, 540520, 540453, 540461, A61K 3155, C07D22332

Patent

active

052429113

ABSTRACT:
A series of bridged bicyclic imide compounds having a 4-(4-[2-pyrimidinyl]-1-piperazinyl)butyl group attached to the imide nitrogen are useful for alleviating the symptoms of anxiety and depression in human subjects.

REFERENCES:
patent: 3717634 (1973-02-01), Wu et al.
patent: 3907801 (1975-09-01), Wu et al.
patent: 4006233 (1977-02-01), Shepard et al.
patent: 4173646 (1979-11-01), Shepard et al.
patent: 4182763 (1980-01-01), Casten et al.
patent: 4423049 (1983-12-01), Temple, Jr.
patent: 4507303 (1985-05-01), Ishizumi et al.
patent: 4543355 (1985-09-01), Ishizumi et al.
patent: 4562255 (1985-12-01), Freed et al.
patent: 4748240 (1988-05-01), Stack et al.
Chem. Abst. vol. 101, 1984, Abst. No. 23432K abstracting Korgeonkar et al. J. Indian Soc. (1983) vol. 60, No. 9, pp. 874-876.

Affiliated with

Also associated with

Rating

Bridged bicyclic imides as anxiolytics and antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bridged bicyclic imides as anxiolytics and antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bridged bicyclic imides as anxiolytics and antidepressants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-487917